Esterified Estrogens and Methyltestosterone 1.25 mg/1, 2.5 mg/1 TABLET
FDA Drug Information
Indications & Usage
INDICATIONS AND USAGE Esterified Estrogens and Methyltestosterone Full and Half-Strength Tablets are indicated in the: • Treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone. (There is no evidence that estrogens are effective for nervous symptoms or depression without associated vasomotor symptoms, and they should not be used to treat such conditions.) • Esterified Estrogens and Methyltestosterone Full and Half-Strengt…
Important Warnings
WARNINGS See BOXED WARNINGS . Warnings Associated with Estrogens Cardiovascular Disorders Estrogen and estrogen/progestin therapy has been associated with an increased risk of cardiovascular events such as myocardial infarction and stroke, as well as venous thrombosis and pulmonary embolism (venous thromboembolism or VTE). Should any of these occur or be suspected, estrogens should be discontinued…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Esterified Estrogens and Methyltestosterone NDC Codes
Wholesale and compliance resources
Order NDC 62559-0149-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).